Salar Roshan, MBA

Vice President, Head of Corporate Development
What inspires you every day at Rain?

Rain’s limitless persistence to help patients with debilitating cancers.

Salar serves as Rain’s Vice President and Head of Corporate Development, and is responsible for the development and execution of Rain’s corporate and business development strategy. He has more than 15 years of experience in corporate development, portfolio strategy, and clinical research across hematology and oncology. Prior to joining Rain, Salar served as the Senior Director of Business Development and Licensing at MorphoSys and was a key member of the business development team that led the acquisition of Constellation Pharmaceuticals. Prior to that, Salar was the Vice President of Business Development & Transactions at Anchiano Therapeutics. He has also held roles of increasing responsibility at Curis, Baxalta, Baxter Biosciences, Ironwood Pharmaceuticals, Takeda, Millennium Pharmaceuticals, and Genzyme. Salar holds a BS from Northeastern University, and an MS in finance and MBA from the Kelley School of Business at Indiana University.

Meet the Rest of the Team